GlassScriptPhysician profile
Myung Hoon Lee
NPI 1821175811
$5,322.59
in general payments reported to CMS, 2019-2025
19 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,537 · 2020: $1,580 · 2021: $2,182 · 2023: $23.92.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $23.92.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $23.92 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Amgen INC. | $779.06 | 2019-2021 | |
| Astrazeneca Pharmaceuticals LP | $693.19 | 2019-2021 | |
| Daiichi Sankyo INC. | $654.40 | 2019-2021 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $611.33 | 2019-2021 | |
| Novo Nordisk INC | $581.86 | 2019-2021 | |
| Abbvie INC. | $387.26 | 2019-2021 | |
| Pfizer INC. | $306.81 | 2019-2023 | |
| Merck Sharp & Dohme LLC | $286.51 | 2019-2021 | |
| Kvk-Tech, INC. | $223.74 | 2019 | |
| Sanofi-Aventis U.S. LLC | $209.00 | 2019-2020 | |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $204.13 | 2019-2021 | |
| Lilly USA, LLC | $91.95 | 2019-2020 | |
| Bayer Healthcare Pharmaceuticals INC. | $71.00 | 2021 | |
| Nestle Healthcare Nutrition INC. | $58.97 | 2020-2021 | |
| Glaxosmithkline, LLC. | $43.29 | 2019-2020 |
Show all 19 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Amarin Pharma, INC. | $40.37 | 2021 | |
| Arbor Pharmaceuticals, INC. | $39.61 | 2019 | |
| Novartis Pharmaceuticals Corporation | $23.03 | 2019 | |
| Allergan, INC. | $17.08 | 2020 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Myung Lee listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.